Alnylam Pharmaceuticals reported $610.66M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amgen AMGN:US $ 14842M 257M
Arena Pharmaceuticals ARNA:US $ 53.36M 11.48M
Arrowhead Research ARWR:US $ 146.54M 48.9M
Avrobio Inc AVRO:US $ 22.79M 5.84M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Dicerna Pharmaceuticals DRNA:US $ 239.3M 31.64M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Mirati Therapeutics MRTX:US $ 122.08M 58.79M
Moderna Inc MRNA:US 9.96B 1.12B
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Novartis NVS:US $ 29880M 247M
Ptc Therapeutics PTCT:US $ 465.26M 174.3M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Sangamo Biosciences SGMO:US $ 131.9M 5.04M
Sarepta Therapeutics SRPT:US $ 373.44M 51.58M
Takeda 4502:JP Y 1918750M 273984M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
Xencor XNCR:US $ 44.32M 1.64M
YTE INCY:US $ 742.71M 82.39M